Potential reverse spin bias of cannabinoids versus pharmaceutical analgesics for pain treatment: a systematic review based critical interpretive synthesis of meta-analyses.
- 1Department of Nursing, Faculty of Health Sciences, Ariel University, 40700, Ariel, Israel. [email protected].
- 2Department of Nursing, Faculty of Health Sciences, Ariel University, 40700, Ariel, Israel.
Abstract
Background
Cannabinoid-based medicines and conventional pharmaceutical analgesics often demonstrate similarly modest analgesic effects in randomized controlled trials (RCTs), yet meta-analyses of these treatment classes frequently reach different interpretive conclusions. We examined whether this divergence was compatible with interpretive asymmetry, including potential reverse spin bias, defined as narrative framing that is more cautious, negative, or dismissive than expected based on reported efficacy results.Methods
We conducted a critical interpretive synthesis of meta-analyses evaluating cannabinoids and pharmaceutical analgesics for pain. Searches of PubMed, Google Scholar, and reference lists were completed through July 2025. Eligible reviews included double-blind RCTs reporting pain-intensity outcomes. Methodological quality was assessed using AMSTAR-2. For each meta-analysis, pooled efficacy estimates, Results-section wording, and conclusion direction were extracted. Reverse spin bias was assessed at the publication level by comparing reported efficacy findings with narrative conclusions.Results
Twenty-four cannabinoid meta-analyses, contributing 27 analyzable interventions, and 15 pharmaceutical analgesic meta-analyses, contributing 47 analyzable interventions, were included. Median pooled pain-relief effect sizes were similar in the cannabinoids and pharmaceutical analgesics literatures, with a small estimated between-class difference of approximately 0.02 effect-size units. At the publication level, positive conclusions were less frequent in cannabinoid publications than in pharmaceutical analgesic publications (n = 3/24 [12.5%] vs. n = 11/15 [73.3%]; risk difference -60.8 percentage points, approximate 95% CI -86.8 to -34.8). Potential reverse spin bias was more frequent in cannabinoid publications than in pharmaceutical analgesic publications (n = 19/24 [79.2%] vs. n = 2/15 [13.3%]; risk difference 65.8 percentage points, approximate 95% CI 42.2 to 89.5).Conclusions
Cannabinoid and pharmaceutical analgesic meta-analyses showed similar pooled analgesic efficacy but different interpretive framing. Potential reverse spin bias may be one explanation for the more cautious conclusion framing observed in cannabinoid reviews, suggesting that narrative interpretation and other contextual factors may contribute to divergent conclusions in the pain treatment literature.
Related
- Thermal Conversion of Cannabinoids in Hemp Flower: Decarboxylation Kinetics and Potential Accumulation of Δ9-Tetrahydrocannabinol
- Effectiveness and safety of different administration routes of medical cannabis or cannabinoids for chronic pain in adults: a systematic review and network meta-analysis with GRADE assessment
- Best practices for patient authorship and involvement in pharmaceutical industry peer-reviewed publications: systematic literature review and qualitative evidence synthesis
- Effectiveness of oral and inhaled repurposed and antiviral pharmaceutical treatments for acute SARS-CoV-2 in outpatient settings: a systematic review of 124 randomized trials.
- Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives
BibTeX
@article{aviram2026potential,
title = {{Potential reverse spin bias of cannabinoids versus pharmaceutical analgesics for pain treatment: a systematic review based critical interpretive synthesis of meta-analyses.}},
author = {Joshua Aviram and Yulia Gendler},
journal = {Research integrity and peer review},
year = {2026},
month = aug,
doi = {10.1186/s41073-026-00243-w},
url = {https://europepmc.org/article/MED/42972429},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Potential reverse spin bias of cannabinoids versus pharmaceutical analgesics for pain treatment: a systematic review based critical interpretive synthesis of meta-analyses.
AU - Joshua Aviram
AU - Yulia Gendler
PY - 2026
DA - 2026/08/05
JO - Research integrity and peer review
DO - 10.1186/s41073-026-00243-w
UR - https://europepmc.org/article/MED/42972429
AB - Background Cannabinoid-based medicines and conventional pharmaceutical analgesics often demonstrate similarly modest analgesic effects in randomized controlled trials (RCTs), yet meta-analyses of these treatment classes frequently reach different interpretive conclusions. We examined whether this divergence was compatible with interpretive asymmetry, including potential reverse spin bias, defined as narrative framing that is more cautious, negative, or dismissive than expected based on reported efficacy results.Methods We conducted a critical interpretive synthesis of meta-analyses evaluating cannabinoids and pharmaceutical analgesics for pain. Searches of PubMed, Google Scholar, and reference lists were completed through July 2025. Eligible reviews included double-blind RCTs reporting pain-intensity outcomes. Methodological quality was assessed using AMSTAR-2. For each meta-analysis, pooled efficacy estimates, Results-section wording, and conclusion direction were extracted. Reverse spin bias was assessed at the publication level by comparing reported efficacy findings with narrative conclusions.Results Twenty-four cannabinoid meta-analyses, contributing 27 analyzable interventions, and 15 pharmaceutical analgesic meta-analyses, contributing 47 analyzable interventions, were included. Median pooled pain-relief effect sizes were similar in the cannabinoids and pharmaceutical analgesics literatures, with a small estimated between-class difference of approximately 0.02 effect-size units. At the publication level, positive conclusions were less frequent in cannabinoid publications than in pharmaceutical analgesic publications (n = 3/24 [12.5%] vs. n = 11/15 [73.3%]; risk difference -60.8 percentage points, approximate 95% CI -86.8 to -34.8). Potential reverse spin bias was more frequent in cannabinoid publications than in pharmaceutical analgesic publications (n = 19/24 [79.2%] vs. n = 2/15 [13.3%]; risk difference 65.8 percentage points, approximate 95% CI 42.2 to 89.5).Conclusions Cannabinoid and pharmaceutical analgesic meta-analyses showed similar pooled analgesic efficacy but different interpretive framing. Potential reverse spin bias may be one explanation for the more cautious conclusion framing observed in cannabinoid reviews, suggesting that narrative interpretation and other contextual factors may contribute to divergent conclusions in the pain treatment literature.
SN - 2058-8615
ER -